Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-05-17
1993-03-30
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3155
Patent
active
051984369
ABSTRACT:
A method of therapeutically administering certain BZ.sub.1 specific trifluorobenzodiazepines in order to maximize the BZ.sub.1 effects and minimize the BZ.sub.2 effects on the human central nervous system in order to maximize the anti-anxiety, anticonvulsant and hypnotic effects and minimize the ataxic and incoordination effects of the drug.
REFERENCES:
patent: 3694552 (1972-09-01), Hester, Jr.
patent: 3920818 (1975-11-01), Steinman
patent: 4009271 (1977-02-01), vonBebenburg et al.
patent: 4088756 (1978-05-01), Voorhees
patent: 4229447 (1980-10-01), Porter
patent: 4302468 (1981-11-01), Rackur et al.
patent: 4305952 (1981-12-01), Rackur et al.
patent: 4444781 (1984-04-01), Hester, Jr.
patent: 4478822 (1984-10-01), Haslam et al.
patent: 4595684 (1986-06-01), Bennett
Hilbert et al., "Effect of Sleep on Quazepam Kinetics"; Clin. Pharmacol. Ther.; Jul., 1984, pp. 99-104.
Chung et al.; "Multiple-dose Quazepam Kinetics"; Clin. Pharmacol. Ther.; Apr., 1984; pp. 520-524.
Ongini and Barnett; "Hypnotic Specificity of Benzodiapepines"; Clinical Neuropharmacology; V. 7, Suppl. 1, 1984; pp. 812-813.
Mennini et al.; "Benzodiazepine Receptor Occupation `In Vivo` and Pharmacological Activity"; Clin. Neuropharm.; V. 7, Supp. 1, 1984; pp. 660-661.
Braestrup et al.; "Interaction of B-Carbolines with Benzodiazepine Receptors"; Clin. Neuropharm.; V. 7, Supp. 1, 1984; pp. 664-665.
Ticku; "Allosteric Modulation of Benzodiazepine GABA-Receptor-Ionophore Complex by Nonbenzodiazepines"; Clin. Neuro.; V. 7, Supp. 1, 1984; pp. 892-893.
Ongini et al.; "Effects of a New Benzodiazepine Hypnotic (Quazepam-SCH 16134) on EEG Synchronization"; Neuropharmacology; V. 21, 1982; pp. 405-412.
Beer; "A New Generation of Anziolytics"; Clin. Neuropharm.; V. 7, Supp. 1, 1984; pp. 888-889.
Ongini et al.; "Pharmacological Studies with Quazepam, a New Benzodiazepine Hypnotic"; Drug Res.; V. 32(II), No. 11, 1981; pp. 1456-1462.
Nikaido et al.; "Comparison of the Effects of Quazepam and Triazolam on Cognitive-Neuromotor Performance"; Psychopharm.; v. 92, 1987; pp. 459-464.
Depoortere et al.; "Zolpidem, a Novel Nonbenzodiazepine Hypnotic"; Journ. of Pharmacol. & Exper. Ther.; v. 237, n. 2; pp. 649-658 1986.
Nicholson et al.; "Hypnotic Activity of an Imidazo-Pyridine (Zolpidem)"; Br. J. Clin. Pharmac.; v. 21, 1986; pp. 205-211.
Sanger et al.; "The Behavioral Profile of Sopidem, a Novel Hypnotic Drug of Imidazopyridine Structure"; Phys. & Behav.; v. 41, 1987; pp. 235-240.
Sanger; "Further Investigation of the Stimulus Properties of Chlodiazepoxide and Zolpidem"; Psychopharm.; v. 93, 1987; pp. 365-368.
Cashman et al.; "Assessment of a New Hypnotic Imidazo-Pyridine (Zolpidem) as Oral Premedication"; Br. J. Clin. Pharmac.; v. 24, 1987; pp. 85-92.
Claustre et al.; "Pharmacological Studies on Stress-Induced Increase in Frontal Cortical Dopamine Metabolism"; J. Pharm. & Exp. Ther.; v. 238, n. 2; pp. 693-700 1986.
Zampaglione et al.; "Disposition and Metabolic Fate of .sup.14 C-Quazepam in Man"; Drug Metabolism and Disposition; v. 13, n. 1; pp. 25-29 1986.
Pritchett et al.; "Type I and Type II GABA.sub.A -Benzodiazepine Receptors Produced in Transfected Cells"; This Week in Science; v. 24, n. 5 (Sep., 1989); pp. 1389-1392.
Publication in the Index Nominum 1987 entitled "Repertoire des substances medicamenteuses Arzneistoff-Synonymverzeichnis International Drug Directory", 1987, p. 905, Soc. Suise de Pharmacie, Zurich, CH. on Quazepam.
Publication in The Merck Index-An Encyclopedia of Chemicals, Drugs, and Biologicals, 1983 10th ed., editor M. Windholz et al. p. 661, Merck & Co., Inc. Rayway, N.J. on Halazepam.
Publication in Pharmaceutical Research, vol. 5, No. 6, Jun. 1988, pp. 365-368, Plenum Press, New York, U.S. by Ellinwood, Jr. et al. entitled "Liquid Chromatographic Assay and Pharmacokinetics of Quazepam and Its Metabolities Following Sublingual Administration of Quazepam".
Publication in Life Sciences, vol. 39, No. 2, 1986, pp. 161-168, Pergamon Journal Ltd.; by J. M. Hilbert et al. entitled "Relationships of Brain and Plasma Levels of Quazepam Flurazepam and their Metabolities with Pharmacological Activity in Mice".
Publication in Allgemeine Pharmacology and Toxicology, 1987, 5th ed., pp. 40-41, Bi Wissenschaftsverlag, Mannheim, Del., by F. W. Fenschler et al., entitled "Allgemeine and Special Pharmacology and Toxicology".
Publication in Drug Metabolism and Disposition, vol. 12, No. 4, 1984, pp. 452-459, The American Society for Pharmacology and Experimental Therapeutics, US; by J. Hilbert et al., entitled "The Disposition and Metabolism of a Hypnotic Benzodiazepine, Quazepam, in the Hamster and Mouse".
Ellinwood, Jr. Everett H.
Gupta Samir K.
Criares Theodore J.
Jenkins Richard E.
Waddell Frederick E.
LandOfFree
Intraoral dosing method of administering trifluorobenzodiazepine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraoral dosing method of administering trifluorobenzodiazepine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraoral dosing method of administering trifluorobenzodiazepine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281159